Cannabis use characteristics and posttraumatic stress disorder-related outcomes among Canadian Veterans with chronic pain

Abstract: Previous research on the relationship between cannabis and posttraumatic stress disorder (PTSD) has produced equivocal Results:. One explanation is that differences in cannabis use characteristics (e.g., medicinal vs. recreational use, route of administration, THC to CBD ratio, and grams per day) are associated with differences in PTSD severity. Using data from a previous cross-sectional study, we performed a series of MANOVAs to examine how cannabis use, cannabis use characteristics, sex, and talk therapy attendance are associated with PTSD severity, psychological distress (i.e., depression and anxiety), and insomnia in a sample of Canadian veterans with chronic pain and a history of trauma (N = 513). We also performed descriptive analysis on participants’ demographics, military history, and cannabis use. Participants with a cannabis prescription and/or who attended talk therapy tended to have higher PTSD severity than those who did not. Cannabis use, sex, route of administration, THC to CBD ratio, and grams per day, were not significantly correlated with PTSD-related outcomes. However, descriptive analysis showed that the majority of those who used cannabis reported that it benefited their mental health. We speculate that veterans with more severe PTSD are more likely to seek out treatment in the form of prescribed cannabis or talk therapy; and that the perceived effect of cannabis on PTSD differs from the measured effect due to cannabis only causing a short-term reduction in PTSD symptoms.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.